Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,389 | 320 | 98.6% |
| Education | $75.14 | 3 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,174 | 86 | $0 (2024) |
| Janssen Biotech, Inc. | $817.62 | 40 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $774.46 | 46 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $645.44 | 40 | $0 (2024) |
| Ardelyx, Inc. | $274.83 | 9 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $267.41 | 18 | $0 (2024) |
| Gilead Sciences, Inc. | $196.48 | 10 | $0 (2022) |
| Celgene Corporation | $191.51 | 11 | $0 (2023) |
| QOL Medical, LLC | $134.40 | 5 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $130.97 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,326 | 71 | ABBVIE INC. ($265.86) |
| 2023 | $1,508 | 84 | ABBVIE INC. ($276.87) |
| 2022 | $1,446 | 91 | ABBVIE INC. ($343.13) |
| 2021 | $1,185 | 77 | AbbVie Inc. ($288.34) |
All Payment Transactions
323 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/20/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: LIVER DISEASE | ||||||
| 11/15/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $13.98 | General |
| Category: GI | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $24.48 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/11/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Immunology | ||||||
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.96 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/27/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Gastroenterology | ||||||
| 09/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: LIVER DISEASE | ||||||
| 09/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Gastroenterology | ||||||
| 09/04/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Rare Disease | ||||||
| 08/28/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Genetic Disease | ||||||
| 08/23/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 440 | 539 | $101,750 | $33,357 |
| 2022 | 3 | 303 | 348 | $63,910 | $22,358 |
| 2021 | 2 | 267 | 315 | $53,575 | $18,131 |
| 2020 | 3 | 221 | 255 | $34,975 | $11,803 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 231 | 291 | $43,650 | $15,123 | 34.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 121 | 160 | $36,000 | $11,563 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $14,850 | $5,070 | 34.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $4,000 | $1,351 | 33.8% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 13 | 13 | $3,250 | $251.42 | 7.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 123 | 146 | $32,850 | $10,728 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 161 | 183 | $25,975 | $9,829 | 37.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $5,085 | $1,800 | 35.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 147 | 173 | $21,625 | $9,576 | 44.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 120 | 142 | $31,950 | $8,555 | 26.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 171 | 204 | $25,500 | $9,063 | 35.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 34 | 35 | $7,875 | $2,364 | 30.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 16 | 16 | $1,600 | $375.86 | 23.5% |
About Jayda Rupp, APRN
Jayda Rupp, APRN is a Nurse Practitioner healthcare provider based in Topeka, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2015. The National Provider Identifier (NPI) number assigned to this provider is 1063892677.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jayda Rupp, APRN has received a total of $5,464 in payments from pharmaceutical and medical device companies, with $1,326 received in 2024. These payments were reported across 323 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,389).
As a Medicare-enrolled provider, Rupp has provided services to 1,231 Medicare beneficiaries, totaling 1,457 services with total Medicare billing of $85,649. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Topeka, KS
- Active Since 06/09/2015
- Last Updated 06/09/2015
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1063892677
Products in Payments
- ENTYVIO (Biological) $757.27
- XIFAXAN (Drug) $528.19
- REMICADE (Biological) $426.69
- STELARA (Biological) $349.54
- IBSRELA (Drug) $274.83
- OCALIVA (Drug) $267.41
- RINVOQ (Biological) $251.37
- LINZESS (Drug) $221.30
- SKYRIZI (Biological) $198.92
- HUMIRA (Biological) $197.34
- DUPIXENT (Biological) $196.89
- MAVYRET (Drug) $195.03
- ZEPOSIA (Drug) $191.51
- DIFICID (Drug) $120.75
- TRULANCE (Drug) $117.25
- Linzess (Drug) $97.56
- SUCRAID (Drug) $74.74
- VIBERZI (Drug) $68.08
- ZENPEP (Drug) $64.46
- RENFLEXIS (Drug) $64.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Topeka
Gary Graf, Aprn, APRN
Nurse Practitioner — Payments: $618,746
Shannon Gregg, Aprn, APRN
Nurse Practitioner — Payments: $86,847
Kelli Bradbury, Aprn, APRN
Nurse Practitioner — Payments: $12,244
Alexandra Heeren, Aprn, APRN
Nurse Practitioner — Payments: $6,355
Laura Welborn, Arnp, ARNP
Nurse Practitioner — Payments: $5,528
Amie Wunder, Aprn, APRN
Nurse Practitioner — Payments: $5,461